Covington advised Imdex Ltd. on the deal. Imdex Ltd., a global mining technology company that enables drilling contractors and resource companies to find, define and mine...
Imdex’s Victory before the U.S. International Trade Commission
Caris Life Sciences’ $400 Million Secured Debt Financing
Covington advised OrbiMed on the deal. OrbiMed acted as the lead investor in a $400 million senior secured term loan facility provided to Caris Life Sciences, a...
Petrichor’s $30 Million Financing of VERO Biotech Inc.
Covington advised Petrichor on the deal. Petrichor, a leading healthcare-dedicated growth capital provider, announced its $30 million financing of VERO Biotech Inc., a commercial-stage healthcare business dedicated...
Dedrone Holdings’ Acquisition of Aerial Armor
Crowell & Moring advised founders of Aerial Armor on the deal. Aerial Armor announced the sale of the company to Dedrone Holdings Inc., a leader in...
AstraZeneca’s Acquisition of CinCor Pharma
Covington & Burling advised AstraZeneca. Skadden represented Centerview Partners LLC, the exclusive financial advisor to CinCor Pharma Inc. Cooley advised CinCor Pharma. CinCor Pharma Inc. (“CinCor”)...
Advent International’s Acquisition of Maxar Technologies
Wachtell, Lipton, Rosen & Katz advised Maxar on the deal. Milbank served as Maxar’s legal advisor with respect to certain space industry and regulatory matters. Weil,...
Indivior’s $145 Million Acquisition of Opiant Pharmaceuticals
Covington & Burling LLP advised Indivior, while Latham & Watkins LLP represented Opiant in the transaction. Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) has entered into a definitive...
Roivant Sciences’ $150 Million Equity Offering
Davis Polk advised Roivant Sciences Ltd. in the deal, while Covington represented the underwriter, Cantor Fitzgerald. Roivant Sciences Ltd. announced its debut SEC-registered offering of 30,000,000...
Marinus Pharmaceuticals’ $60 Million Public Offering
Covington represented the underwriters on the deal. Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders,...
Insmed Incorporated’s $775 Million Financing
Covington advised Insmed Incorporated on the deal while Fenwick represented Pharmakon. Walder Wyss advised the funds managed by Pharmakon Advisors, LP, BioPharma Credit and OrbiMed. Akin...
Immunic’s $60 Million Private Placement Equity Financing
Covington represented the placement agents on the deal. Immunic, Inc. (Nasdaq: IMUX) (“Immunic” or the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of selective oral...
Immatics’ $110 Million Shares Offering
Davis Polk advised Immatics on the offering while Covington represented underwriters. Immatics N.V. executed its $110 million SEC-registered offering of ordinary shares. The ordinary shares are...